
### [MONDO:0016113](http://purl.obolibrary.org/obo/MONDO_0016113)
**Label:** bulbospinal muscular atrophy

**Subclasses:** [MONDO:0012890](http://purl.obolibrary.org/obo/MONDO_0012890) (pontocerebellar hypoplasia type 2B), [MONDO:0016115](http://purl.obolibrary.org/obo/MONDO_0016115) (bulbospinal muscular atrophy of adult), [MONDO:0016114](http://purl.obolibrary.org/obo/MONDO_0016114) (bulbospinal muscular atrophy of childhood), [MONDO:0014874](http://purl.obolibrary.org/obo/MONDO_0014874) (pontocerebellar hypoplasia, type 2F; PCH2F), [MONDO:0016116](http://purl.obolibrary.org/obo/MONDO_0016116) (generalized bulbospinal muscular atrophy), [MONDO:0008890](http://purl.obolibrary.org/obo/MONDO_0008890) (progressive bulbar palsy), [MONDO:0000902](http://purl.obolibrary.org/obo/MONDO_0000902) (agenesis of the corpus callosum with peripheral neuropathy), [MONDO:0008891](http://purl.obolibrary.org/obo/MONDO_0008891) (riboflavin transporter deficiency), [MONDO:0016396](http://purl.obolibrary.org/obo/MONDO_0016396) (pontocerebellar hypoplasia type 1), [MONDO:0012891](http://purl.obolibrary.org/obo/MONDO_0012891) (pontocerebellar hypoplasia type 2C), [MONDO:0014485](http://purl.obolibrary.org/obo/MONDO_0014485) (pontocerebellar hypoplasia, type 1C), [MONDO:0016131](http://purl.obolibrary.org/obo/MONDO_0016131) (spinal muscular atrophy associated with central nervous system anomaly), [MONDO:0015250](http://purl.obolibrary.org/obo/MONDO_0015250) (spinal atrophy-ophthalmoplegia-pyramidal syndrome), [MONDO:0019132](http://purl.obolibrary.org/obo/MONDO_0019132) (spinal muscular atrophy-Dandy-Walker malformation-cataracts syndrome), [MONDO:0010190](http://purl.obolibrary.org/obo/MONDO_0010190) (pontocerebellar hypoplasia type 2A), [MONDO:0012608](http://purl.obolibrary.org/obo/MONDO_0012608) (autosomal recessive lower motor neuron disease with childhood onset), [MONDO:0013438](http://purl.obolibrary.org/obo/MONDO_0013438) (pontocerebellar hypoplasia type 2D), [MONDO:0013867](http://purl.obolibrary.org/obo/MONDO_0013867) (brown-Vialetto-van Laere syndrome 2), [MONDO:0010735](http://purl.obolibrary.org/obo/MONDO_0010735) (Kennedy's disease), [MONDO:0013853](http://purl.obolibrary.org/obo/MONDO_0013853) (pontocerebellar hypoplasia type 1B), [MONDO:0016759](http://purl.obolibrary.org/obo/MONDO_0016759) (pontocerebellar hypoplasia type 2), [MONDO:0011866](http://purl.obolibrary.org/obo/MONDO_0011866) (pontocerebellar hypoplasia type 1A), 

**Mapped go classes:** [GO:0008584](http://purl.obolibrary.org/obo/GO_0008584) (male gonad development), [GO:0000978](http://purl.obolibrary.org/obo/GO_0000978) (RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0051092](http://purl.obolibrary.org/obo/GO_0051092) (positive regulation of NF-kappaB transcription factor activity), [GO:0061458](http://purl.obolibrary.org/obo/GO_0061458) (reproductive system development), [GO:0000178](http://purl.obolibrary.org/obo/GO_0000178) (exosome (RNase complex)), [GO:0045892](http://purl.obolibrary.org/obo/GO_0045892) (negative regulation of transcription, DNA-templated), [GO:0001701](http://purl.obolibrary.org/obo/GO_0001701) (in utero embryonic development), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0050790](http://purl.obolibrary.org/obo/GO_0050790) (regulation of catalytic activity), [GO:0030145](http://purl.obolibrary.org/obo/GO_0030145) (manganese ion binding), [GO:0030027](http://purl.obolibrary.org/obo/GO_0030027) (lamellipodium), [GO:0019901](http://purl.obolibrary.org/obo/GO_0019901) (protein kinase binding), [GO:0048808](http://purl.obolibrary.org/obo/GO_0048808) (male genitalia morphogenesis), [GO:0019904](http://purl.obolibrary.org/obo/GO_0019904) (protein domain specific binding), [GO:0007268](http://purl.obolibrary.org/obo/GO_0007268) (chemical synaptic transmission), [GO:0009566](http://purl.obolibrary.org/obo/GO_0009566) (fertilization), [GO:0004672](http://purl.obolibrary.org/obo/GO_0004672) (protein kinase activity), [GO:0005089](http://purl.obolibrary.org/obo/GO_0005089) (Rho guanyl-nucleotide exchange factor activity), [GO:0043234](http://purl.obolibrary.org/obo/GO_0043234) (protein complex), [GO:0004674](http://purl.obolibrary.org/obo/GO_0004674) (protein serine/threonine kinase activity), [GO:0060599](http://purl.obolibrary.org/obo/GO_0060599) (lateral sprouting involved in mammary gland duct morphogenesis), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0000981](http://purl.obolibrary.org/obo/GO_0000981) (RNA polymerase II transcription factor activity, sequence-specific DNA binding), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0030139](http://purl.obolibrary.org/obo/GO_0030139) (endocytic vesicle), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0035826](http://purl.obolibrary.org/obo/GO_0035826) (rubidium ion transport), [GO:0050681](http://purl.obolibrary.org/obo/GO_0050681) (androgen receptor binding), [GO:0035827](http://purl.obolibrary.org/obo/GO_0035827) (rubidium ion transmembrane transporter activity), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0050680](http://purl.obolibrary.org/obo/GO_0050680) (negative regulation of epithelial cell proliferation), [GO:0032553](http://purl.obolibrary.org/obo/GO_0032553) (ribonucleotide binding), [GO:0035264](http://purl.obolibrary.org/obo/GO_0035264) (multicellular organism growth), [GO:0035023](http://purl.obolibrary.org/obo/GO_0035023) (regulation of Rho protein signal transduction), [GO:0043009](http://purl.obolibrary.org/obo/GO_0043009) (chordate embryonic development), [GO:0043928](http://purl.obolibrary.org/obo/GO_0043928) (exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay), [GO:0043123](http://purl.obolibrary.org/obo/GO_0043123) (positive regulation of I-kappaB kinase/NF-kappaB signaling), [GO:0044212](http://purl.obolibrary.org/obo/GO_0044212) (transcription regulatory region DNA binding), [GO:0006388](http://purl.obolibrary.org/obo/GO_0006388) (tRNA splicing, via endonucleolytic cleavage and ligation), [GO:0005730](http://purl.obolibrary.org/obo/GO_0005730) (nucleolus), [GO:0004882](http://purl.obolibrary.org/obo/GO_0004882) (androgen receptor activity), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0071394](http://purl.obolibrary.org/obo/GO_0071394) (cellular response to testosterone stimulus), [GO:0051301](http://purl.obolibrary.org/obo/GO_0051301) (cell division), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0006811](http://purl.obolibrary.org/obo/GO_0006811) (ion transport), [GO:0034605](http://purl.obolibrary.org/obo/GO_0034605) (cellular response to heat), [GO:0071035](http://purl.obolibrary.org/obo/GO_0071035) (nuclear polyadenylation-dependent rRNA catabolic process), [GO:0004879](http://purl.obolibrary.org/obo/GO_0004879) (nuclear receptor activity), [GO:0071034](http://purl.obolibrary.org/obo/GO_0071034) (CUT catabolic process), [GO:0004518](http://purl.obolibrary.org/obo/GO_0004518) (nuclease activity), [GO:0019102](http://purl.obolibrary.org/obo/GO_0019102) (male somatic sex determination), [GO:0071038](http://purl.obolibrary.org/obo/GO_0071038) (nuclear polyadenylation-dependent tRNA catabolic process), [GO:0006396](http://purl.obolibrary.org/obo/GO_0006396) (RNA processing), [GO:0006397](http://purl.obolibrary.org/obo/GO_0006397) (mRNA processing), [GO:0003682](http://purl.obolibrary.org/obo/GO_0003682) (chromatin binding), [GO:0005741](http://purl.obolibrary.org/obo/GO_0005741) (mitochondrial outer membrane), [GO:0000049](http://purl.obolibrary.org/obo/GO_0000049) (tRNA binding), [GO:0022850](http://purl.obolibrary.org/obo/GO_0022850) (serotonin-gated cation-selective channel activity), [GO:0007369](http://purl.obolibrary.org/obo/GO_0007369) (gastrulation), [GO:0000177](http://purl.obolibrary.org/obo/GO_0000177) (cytoplasmic exosome (RNase complex)), [GO:0071383](http://purl.obolibrary.org/obo/GO_0071383) (cellular response to steroid hormone stimulus), [GO:0000176](http://purl.obolibrary.org/obo/GO_0000176) (nuclear exosome (RNase complex)), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005856](http://purl.obolibrary.org/obo/GO_0005856) (cytoskeleton), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0004527](http://purl.obolibrary.org/obo/GO_0004527) (exonuclease activity), [GO:0072355](http://purl.obolibrary.org/obo/GO_0072355) (histone H3-T3 phosphorylation), [GO:0072354](http://purl.obolibrary.org/obo/GO_0072354) (histone kinase activity (H3-T3 specific)), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0071028](http://purl.obolibrary.org/obo/GO_0071028) (nuclear mRNA surveillance), [GO:2001237](http://purl.obolibrary.org/obo/GO_2001237) (negative regulation of extrinsic apoptotic signaling pathway), [GO:0070974](http://purl.obolibrary.org/obo/GO_0070974) (POU domain binding), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0045726](http://purl.obolibrary.org/obo/GO_0045726) (positive regulation of integrin biosynthetic process), [GO:0060685](http://purl.obolibrary.org/obo/GO_0060685) (regulation of prostatic bud formation), [GO:0045720](http://purl.obolibrary.org/obo/GO_0045720) (negative regulation of integrin biosynthetic process), [GO:0043542](http://purl.obolibrary.org/obo/GO_0043542) (endothelial cell migration), [GO:0005795](http://purl.obolibrary.org/obo/GO_0005795) (Golgi stack), [GO:0006401](http://purl.obolibrary.org/obo/GO_0006401) (RNA catabolic process), [GO:0007605](http://purl.obolibrary.org/obo/GO_0007605) (sensory perception of sound), [GO:0070481](http://purl.obolibrary.org/obo/GO_0070481) (nuclear-transcribed mRNA catabolic process, non-stop decay), [GO:0001077](http://purl.obolibrary.org/obo/GO_0001077) (transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0034427](http://purl.obolibrary.org/obo/GO_0034427) (nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding), [GO:0008033](http://purl.obolibrary.org/obo/GO_0008033) (tRNA processing), [GO:0003382](http://purl.obolibrary.org/obo/GO_0003382) (epithelial cell morphogenesis), [GO:0007620](http://purl.obolibrary.org/obo/GO_0007620) (copulation), [GO:0006412](http://purl.obolibrary.org/obo/GO_0006412) (translation), [GO:0017091](http://purl.obolibrary.org/obo/GO_0017091) (AU-rich element binding), [GO:0097056](http://purl.obolibrary.org/obo/GO_0097056) (selenocysteinyl-tRNA(Sec) biosynthetic process), [GO:0000790](http://purl.obolibrary.org/obo/GO_0000790) (nuclear chromatin), [GO:0001514](http://purl.obolibrary.org/obo/GO_0001514) (selenocysteine incorporation), [GO:0001085](http://purl.obolibrary.org/obo/GO_0001085) (RNA polymerase II transcription factor binding), [GO:0070478](http://purl.obolibrary.org/obo/GO_0070478) (nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay), [GO:0010468](http://purl.obolibrary.org/obo/GO_0010468) (regulation of gene expression), [GO:0030054](http://purl.obolibrary.org/obo/GO_0030054) (cell junction), [GO:0010107](http://purl.obolibrary.org/obo/GO_0010107) (potassium ion import), [GO:0016323](http://purl.obolibrary.org/obo/GO_0016323) (basolateral plasma membrane), [GO:0033327](http://purl.obolibrary.org/obo/GO_0033327) (Leydig cell differentiation), [GO:0008360](http://purl.obolibrary.org/obo/GO_0008360) (regulation of cell shape), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0043568](http://purl.obolibrary.org/obo/GO_0043568) (positive regulation of insulin-like growth factor receptor signaling pathway), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0071476](http://purl.obolibrary.org/obo/GO_0071476) (cellular hypotonic response), [GO:0071477](http://purl.obolibrary.org/obo/GO_0071477) (cellular hypotonic salinity response), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0045190](http://purl.obolibrary.org/obo/GO_0045190) (isotype switching), [GO:1903076](http://purl.obolibrary.org/obo/GO_1903076) (regulation of protein localization to plasma membrane), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0031493](http://purl.obolibrary.org/obo/GO_0031493) (nucleosomal histone binding), [GO:0007283](http://purl.obolibrary.org/obo/GO_0007283) (spermatogenesis), [GO:0060571](http://purl.obolibrary.org/obo/GO_0060571) (morphogenesis of an epithelial fold), [GO:0035175](http://purl.obolibrary.org/obo/GO_0035175) (histone kinase activity (H3-S10 specific)), [GO:0008013](http://purl.obolibrary.org/obo/GO_0008013) (beta-catenin binding), [GO:0008134](http://purl.obolibrary.org/obo/GO_0008134) (transcription factor binding), [GO:0007049](http://purl.obolibrary.org/obo/GO_0007049) (cell cycle), [GO:0032218](http://purl.obolibrary.org/obo/GO_0032218) (riboflavin transport), [GO:0021693](http://purl.obolibrary.org/obo/GO_0021693) (cerebellar Purkinje cell layer structural organization), [GO:0012505](http://purl.obolibrary.org/obo/GO_0012505) (endomembrane system), [GO:0032217](http://purl.obolibrary.org/obo/GO_0032217) (riboflavin transmembrane transporter activity), [GO:0016785](http://purl.obolibrary.org/obo/GO_0016785) (transferase activity, transferring selenium-containing groups), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), [GO:0043628](http://purl.obolibrary.org/obo/GO_0043628) (ncRNA 3'-end processing), [GO:0060520](http://purl.obolibrary.org/obo/GO_0060520) (activation of prostate induction by androgen receptor signaling pathway), [GO:0034475](http://purl.obolibrary.org/obo/GO_0034475) (U4 snRNA 3'-end processing), [GO:0034473](http://purl.obolibrary.org/obo/GO_0034473) (U1 snRNA 3'-end processing), [GO:0045006](http://purl.obolibrary.org/obo/GO_0045006) (DNA deamination), [GO:0060406](http://purl.obolibrary.org/obo/GO_0060406) (positive regulation of penile erection), [GO:0060769](http://purl.obolibrary.org/obo/GO_0060769) (positive regulation of epithelial cell proliferation involved in prostate gland development), [GO:0000214](http://purl.obolibrary.org/obo/GO_0000214) (tRNA-intron endonuclease complex), [GO:0000213](http://purl.obolibrary.org/obo/GO_0000213) (tRNA-intron endonuclease activity), [GO:0048638](http://purl.obolibrary.org/obo/GO_0048638) (regulation of developmental growth), [GO:0043987](http://purl.obolibrary.org/obo/GO_0043987) (histone H3-S10 phosphorylation), [GO:0030425](http://purl.obolibrary.org/obo/GO_0030425) (dendrite), [GO:0003723](http://purl.obolibrary.org/obo/GO_0003723) (RNA binding), [GO:0007409](http://purl.obolibrary.org/obo/GO_0007409) (axonogenesis), [GO:0014734](http://purl.obolibrary.org/obo/GO_0014734) (skeletal muscle hypertrophy), [GO:0030424](http://purl.obolibrary.org/obo/GO_0030424) (axon), [GO:0090502](http://purl.obolibrary.org/obo/GO_0090502) (RNA phosphodiester bond hydrolysis, endonucleolytic), [GO:0090501](http://purl.obolibrary.org/obo/GO_0090501) (RNA phosphodiester bond hydrolysis), [GO:0048645](http://purl.obolibrary.org/obo/GO_0048645) (animal organ formation), [GO:0007420](http://purl.obolibrary.org/obo/GO_0007420) (brain development), [GO:0000467](http://purl.obolibrary.org/obo/GO_0000467) (exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)), [GO:0005911](http://purl.obolibrary.org/obo/GO_0005911) (cell-cell junction), [GO:0051259](http://purl.obolibrary.org/obo/GO_0051259) (protein oligomerization), [GO:0015379](http://purl.obolibrary.org/obo/GO_0015379) (potassium:chloride symporter activity), [GO:0008285](http://purl.obolibrary.org/obo/GO_0008285) (negative regulation of cell proliferation), [GO:0008284](http://purl.obolibrary.org/obo/GO_0008284) (positive regulation of cell proliferation), [GO:0008049](http://purl.obolibrary.org/obo/GO_0008049) (male courtship behavior), [GO:0042552](http://purl.obolibrary.org/obo/GO_0042552) (myelination), [GO:0008289](http://purl.obolibrary.org/obo/GO_0008289) (lipid binding), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0045945](http://purl.obolibrary.org/obo/GO_0045945) (positive regulation of transcription by RNA polymerase III), [GO:0043401](http://purl.obolibrary.org/obo/GO_0043401) (steroid hormone mediated signaling pathway), [GO:0005215](http://purl.obolibrary.org/obo/GO_0005215) (transporter activity), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0001525](http://purl.obolibrary.org/obo/GO_0001525) (angiogenesis), [GO:0003824](http://purl.obolibrary.org/obo/GO_0003824) (catalytic activity), [GO:0072520](http://purl.obolibrary.org/obo/GO_0072520) (seminiferous tubule development), [GO:0003707](http://purl.obolibrary.org/obo/GO_0003707) (steroid hormone receptor activity), [GO:0030521](http://purl.obolibrary.org/obo/GO_0030521) (androgen receptor signaling pathway), [GO:0030522](http://purl.obolibrary.org/obo/GO_0030522) (intracellular receptor signaling pathway), [GO:0042327](http://purl.obolibrary.org/obo/GO_0042327) (positive regulation of phosphorylation), [GO:0090166](http://purl.obolibrary.org/obo/GO_0090166) (Golgi disassembly), [GO:0045830](http://purl.obolibrary.org/obo/GO_0045830) (positive regulation of isotype switching), [GO:0043410](http://purl.obolibrary.org/obo/GO_0043410) (positive regulation of MAPK cascade), [GO:0043534](http://purl.obolibrary.org/obo/GO_0043534) (blood vessel endothelial cell migration), [GO:0005102](http://purl.obolibrary.org/obo/GO_0005102) (receptor binding), [GO:0035767](http://purl.obolibrary.org/obo/GO_0035767) (endothelial cell chemotaxis), [GO:0015079](http://purl.obolibrary.org/obo/GO_0015079) (potassium ion transmembrane transporter activity), [GO:1902476](http://purl.obolibrary.org/obo/GO_1902476) (chloride transmembrane transport), [GO:0016607](http://purl.obolibrary.org/obo/GO_0016607) (nuclear speck), [GO:0046777](http://purl.obolibrary.org/obo/GO_0046777) (protein autophosphorylation), [GO:0006364](http://purl.obolibrary.org/obo/GO_0006364) (rRNA processing), [GO:0000379](http://purl.obolibrary.org/obo/GO_0000379) (tRNA-type intron splice site recognition and cleavage), [GO:0007338](http://purl.obolibrary.org/obo/GO_0007338) (single fertilization), [GO:0071051](http://purl.obolibrary.org/obo/GO_0071051) (polyadenylation-dependent snoRNA 3'-end processing), [GO:0046661](http://purl.obolibrary.org/obo/GO_0046661) (male sex differentiation), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0016973](http://purl.obolibrary.org/obo/GO_0016973) (poly(A)+ mRNA export from nucleus), [GO:0048608](http://purl.obolibrary.org/obo/GO_0048608) (reproductive structure development), [GO:0006810](http://purl.obolibrary.org/obo/GO_0006810) (transport), [GO:0004871](http://purl.obolibrary.org/obo/GO_0004871) (signal transducer activity), [GO:0006379](http://purl.obolibrary.org/obo/GO_0006379) (mRNA cleavage), [GO:0071042](http://purl.obolibrary.org/obo/GO_0071042) (nuclear polyadenylation-dependent mRNA catabolic process), [GO:0098664](http://purl.obolibrary.org/obo/GO_0098664) (G-protein coupled serotonin receptor signaling pathway), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:0071049](http://purl.obolibrary.org/obo/GO_0071049) (nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription), [GO:0018105](http://purl.obolibrary.org/obo/GO_0018105) (peptidyl-serine phosphorylation), [GO:0060740](http://purl.obolibrary.org/obo/GO_0060740) (prostate gland epithelium morphogenesis), [GO:0003073](http://purl.obolibrary.org/obo/GO_0003073) (regulation of systemic arterial blood pressure), [GO:0016829](http://purl.obolibrary.org/obo/GO_0016829) (lyase activity), [GO:0022820](http://purl.obolibrary.org/obo/GO_0022820) (potassium ion symporter activity), [GO:0048854](http://purl.obolibrary.org/obo/GO_0048854) (brain morphogenesis), [GO:0005497](http://purl.obolibrary.org/obo/GO_0005497) (androgen binding), [GO:0060748](http://purl.obolibrary.org/obo/GO_0060748) (tertiary branching involved in mammary gland duct morphogenesis), [GO:0005496](http://purl.obolibrary.org/obo/GO_0005496) (steroid binding), [GO:0006468](http://purl.obolibrary.org/obo/GO_0006468) (protein phosphorylation), [GO:0042995](http://purl.obolibrary.org/obo/GO_0042995) (cell projection), [GO:0060742](http://purl.obolibrary.org/obo/GO_0060742) (epithelial cell differentiation involved in prostate gland development), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0060749](http://purl.obolibrary.org/obo/GO_0060749) (mammary gland alveolus development), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0060736](http://purl.obolibrary.org/obo/GO_0060736) (prostate gland growth), [GO:0045597](http://purl.obolibrary.org/obo/GO_0045597) (positive regulation of cell differentiation), [GO:0009987](http://purl.obolibrary.org/obo/GO_0009987) (cellular process), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0005813](http://purl.obolibrary.org/obo/GO_0005813) (centrosome), [GO:0019098](http://purl.obolibrary.org/obo/GO_0019098) (reproductive behavior), [GO:0070651](http://purl.obolibrary.org/obo/GO_0070651) (nonfunctional rRNA decay), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0033148](http://purl.obolibrary.org/obo/GO_0033148) (positive regulation of intracellular estrogen receptor signaling pathway), [GO:0035327](http://purl.obolibrary.org/obo/GO_0035327) (transcriptionally active chromatin), [GO:0034476](http://purl.obolibrary.org/obo/GO_0034476) (U5 snRNA 3'-end processing), [GO:0051117](http://purl.obolibrary.org/obo/GO_0051117) (ATPase binding), [GO:0019899](http://purl.obolibrary.org/obo/GO_0019899) (enzyme binding), 

**Class expressions from DL-Learner:**

- Thing 55.39%
- [GO:0043633](http://purl.obolibrary.org/obo/GO_0043633) (polyadenylation-dependent RNA catabolic process) 52.11%
- [GO:0071046](http://purl.obolibrary.org/obo/GO_0071046) (nuclear polyadenylation-dependent ncRNA catabolic process) 51.41%
- [GO:0071029](http://purl.obolibrary.org/obo/GO_0071029) (nuclear ncRNA surveillance) 51.41%
- [GO:0071027](http://purl.obolibrary.org/obo/GO_0071027) (nuclear RNA surveillance) 51.41%
- [GO:0071025](http://purl.obolibrary.org/obo/GO_0071025) (RNA surveillance) 51.41%
- [GO:0043634](http://purl.obolibrary.org/obo/GO_0043634) (polyadenylation-dependent ncRNA catabolic process) 51.41%
- [GO:0016075](http://purl.obolibrary.org/obo/GO_0016075) (rRNA catabolic process) 51.41%
- [GO:0043634](http://purl.obolibrary.org/obo/GO_0043634) (polyadenylation-dependent ncRNA catabolic process) and [GO:0071029](http://purl.obolibrary.org/obo/GO_0071029) (nuclear ncRNA surveillance) 51.41%
- [GO:0043634](http://purl.obolibrary.org/obo/GO_0043634) (polyadenylation-dependent ncRNA catabolic process) and [GO:0071027](http://purl.obolibrary.org/obo/GO_0071027) (nuclear RNA surveillance) 51.41%
- [GO:0043634](http://purl.obolibrary.org/obo/GO_0043634) (polyadenylation-dependent ncRNA catabolic process) and [GO:0071025](http://purl.obolibrary.org/obo/GO_0071025) (RNA surveillance) 51.41%
- [GO:0043633](http://purl.obolibrary.org/obo/GO_0043633) (polyadenylation-dependent RNA catabolic process) and [GO:0071029](http://purl.obolibrary.org/obo/GO_0071029) (nuclear ncRNA surveillance) 51.41%
- [GO:0043632](http://purl.obolibrary.org/obo/GO_0043632) (modification-dependent macromolecule catabolic process) and [GO:0071029](http://purl.obolibrary.org/obo/GO_0071029) (nuclear ncRNA surveillance) 51.41%
- [GO:0034661](http://purl.obolibrary.org/obo/GO_0034661) (ncRNA catabolic process) and [GO:0071027](http://purl.obolibrary.org/obo/GO_0071027) (nuclear RNA surveillance) 51.41%
- [GO:0034661](http://purl.obolibrary.org/obo/GO_0034661) (ncRNA catabolic process) and [GO:0071025](http://purl.obolibrary.org/obo/GO_0071025) (RNA surveillance) 51.41%


